Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...
The ‘NLRP3 inflammasome’ is like a control switch. In Alzheimer’s disease, its activation triggers an inflammatory response ...
When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...
The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of Alzheimer's disease globally. The hi ...
A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...
Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...
The past decade has seen a dramatic increase in the technology that allows the detection of minute amounts of disease-related analytes in biofluids. This is ...
A growing body of research suggests that infections, including those caused by common bacteria in gum disease, could ...
Recent research links Alzheimer's disease to bacterial gum infections, specifically the pathogen Porphyromonas gingivalis.
In recent years, a growing number of scientific studies have backed an alarming hypothesis: Alzheimer's disease isn't just a ...
Discover the powerful herbs and vitamins that support neurogenesis and neuroprotection, promoting brain health and resilience ...
Brain inflammation, while a crucial part of the body's immune response, takes on a detrimental role in Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback